Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps

Author:

Kemp P,van der Lans R J L,Otten J J,Adriaensen G F J P M,Benoist L B L,Cornet M E,Hoven D R,Rinia B,Verkest V,Fokkens W J,Reitsma S

Abstract

BACKGROUND: Increased blood eosinophil count (BEC) is common in patients under dupilumab treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). This study investigated the prevalence and consequences of hypereosinophilia and to help define patients at risk. METHODS: Real-life, prospective observational cohort study of patients treated with dupilumab for severe CRSwNP. Eligible patients were adult and biological-naïve (N=334). All BEC values at baseline and during treatment were reported. Patients with a follow-up of ≥ 1 year were included to define patients at risk for hypereosinophilia by comparing baseline BEC values (N=218). Furthermore, clinical characteristics and therapeutic consequences for patients with BEC ≥ 3.0 were noted. RESULTS: Hypereosinophilia developed in a minority of patients, with a peak at week 12 (16.2% with BEC ≥ 1.5, and 1.7% ≥ 3.0) in cross-sectional analysis. BEC ≥ 1.5 developed in 28.9% and BEC ≥ 3.0 in 4.6% of cases with a minimal 1-year follow-up. Baseline BEC was significantly higher for patients developing BEC ≥ 1.5 and BEC ≥3.0, with an optimal cut-off point of 0.96 to predict developing BEC ≥ 3.0. CONCLUSIONS: Blood eosinophil count (BEC) ≥ 1.5 is transient and usually abates with no therapeutic interventions and BEC ≥ 3.0 is rare. Hypereosinophilic syndrome did not occur and switching to a different biological was rarely employed. A baseline BEC of ≥1.0 can be a reason for extra caution.

Publisher

Stichting Nase

Subject

Otorhinolaryngology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3